|
|
Volumn 423, Issue , 2008, Pages 463-472
|
|
DNA vaccination for prostate cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
DNA VACCINE;
GAMMA INTERFERON;
PROSTATE SPECIFIC ANTIGEN;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
BIOSYNTHESIS;
C57BL MOUSE;
CYTOTOXIC T LYMPHOCYTE;
ELECTROCHEMOTHERAPY;
FEMALE;
GENETICS;
HUMAN;
IMMUNOLOGY;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
MOUSE;
PHASE 1 CLINICAL TRIAL;
PLASMID;
PROSTATE TUMOR;
REPORTER GENE;
ANIMALS;
CANCER VACCINES;
CLINICAL TRIALS, PHASE I AS TOPIC;
ELECTROCHEMOTHERAPY;
FEMALE;
GENES, REPORTER;
HUMANS;
INJECTIONS, INTRADERMAL;
INTERFERON TYPE II;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
PLASMIDS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
T-LYMPHOCYTES, CYTOTOXIC;
VACCINES, DNA;
MLCS;
MLOWN;
|
|
EID: 44649084951
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-59745-194-9_36 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
